- À propos de nous
- Qualité et durabilité
- Actualité & nouvelles
- Point of Care
- Oncology Testing
- Research & Industry
- Centre d’expertise
- Clinique & Laboratoire
- Formation et qualification
Oxford Gene Technology (OGT), a Sysmex Group Company, provides world-class genetics research solutions to leading clinical and academic research institutions. The Group's CytoSure™, Cytocell® and SureSeq™ range of microarray, FISH and next generation sequencing products deliver high-quality, high-throughput genetic analysis, enabling accurate identification of the causative variation underlying genetic disease.
They are pioneers in hybridisation technology and a leading provider of clinical research and diagnostic solutions. OGT works in partnership with customers progress the future of genetic-based medicine enabling researchers and clinical decision makers to reach the right care decisions for each patient, every time.
Choose from over one hundred high-quality DNA FISH probes for the detection of genetic aberrations found in cancer and inherited genetic diseases.
Featuring the new constitutional NGS platform for cytogenetic research, alongside a broad range of arrays for rare disease and cancer research.
CytoCell® FISH probes are CE IVD for laboratory professional use only. Not intended for use as stand-alone diagnostics or companion diagnostics. Therapeutic action should not be initiated on the basis of the FISH result alone.
CytoSure®, SureSeq™ and CytoCell myProbes®: For Research Use Only, not for use in diagnostic procedures. Product availability may vary from country to country and is subject to varying regulatory requirements. Contact your local representatives for availability.